Search results for "Rigaku Analytical Devices"

For the Highest Demands in Imaging and Analytics from Any Sample

Overlord™  software is the core of all PAA's laboratory automation products and services  

Used as disinfectant, cleaner and decontaminant on hard, nonporous surfaces, even in neonatal and infant care areas and most medical device matertials, effective against TB, Viruses, Bacteria, Fungi.

Stimulate 24-, 48- or 96-well plates with up to four wavelengths: blue, green, orange and red. Standalone device and pairs with Maestro Pro™ and Edge™

Three decades of experience formed the basis for the design of the, resulting in an istrument with unparalleled accuracy and reliability.  The simplicity of the instrument layout and the extreme facility to change the analytical configuration make it possible to modify the analyzer at any time to accommodate the most diverse analytical applications.Product DetailsFlashEA 1112 is the perfect fit between innovation and tradition…

The first update to Spectrus JS expands its processing capabilities to xC/UV/MS data and introduces ACD/Labs’ industry-leading NMR prediction.

For Your Highest Demands in Sub-nanometer Imaging, Analytics and Sample Flexibility

Complete, automated specimen processing system for front-end pre-analytics in microbiology

Connecting Analytics to Action – Use Instrument Utilization Data to Drive Lab Efficiencies  

The macro™ pipette controller is a reliable and ergonomic alternative to rubber pipette bulbs and other manual aspiration devices. A unique valve system provides precise, one-finger meniscus control that relieves repetitive motion strain from serial pipetting operations, and is simple to operate, even by novice users.

Learn how quantitative DBS technology could transform the clinical utility of dried blood spots and help drive the shift to self-sampling in healthcare

The FDA’s Breakthrough Device designation is granted to products that have the potential to offer a more effective diagnosis of life-threatening diseases

The Amulet is the first and only minimally invasive treatment option to offer immediate closure of the left atrial appendage, so blood-thinning medication isn't needed following implantation

The Collaboration is poised to deliver a range of ready-to-use bioprocess impurity reagent sets